Jiongyu Chen
Overview
Explore the profile of Jiongyu Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
FUNDC1 predicts Poor Prognosis and promotes Progression and Chemoresistance in Endometrial Carcinoma
Tang L, Chen J, Wu Z, Wang L, Lai Y, Chen Z, et al.
J Cancer
. 2024 Dec;
15(20):6490-6504.
PMID: 39668821
Absence of effective prognostic biomarkers and therapeutic targets for reversing chemoresistance of endometrial carcinoma (EC) remains a huge challenge for clinicians. Mitophagy plays a crucial role in carcinogenesis and chemoresistance....
2.
Ji L, Chen J, He L, Zhang F, Deng Z, Lin J, et al.
Oncogene
. 2024 Dec;
44(8):530-544.
PMID: 39623076
Approximately 70% of breast cancer (BC) cases are luminal-type (estrogen receptor-positive, ER+), suitable for endocrine therapy with tamoxifen as the most commonly used drug. However, about 30% of these patients...
3.
Li H, Xiao H, Mai X, Huang S, Chen J, Xiao X
Gene Expr Patterns
. 2024 Aug;
53:119375.
PMID: 39181524
ROBO4 involves in the stabilization of blood vessel and mediates the migration of hematopoietic stem cell and newborn neuron. However, the patterns of expression and regulation are not quite clear....
4.
Scholte M, Ramaekers B, Danopoulos E, Grimm S, Fernandez Coves A, Tian X, et al.
Pharmacoeconomics
. 2024 May;
42(8):829-832.
PMID: 38717708
No abstract available.
5.
Sugden B, Grimm S, Wolff R, Armstrong N, Otten T, Abu-Zahra T, et al.
Pharmacoeconomics
. 2024 May;
42(6):615-618.
PMID: 38713424
No abstract available.
6.
Zhu Y, Chen J, Zhou L, Zhang L, Liu Y, Zhuang Y, et al.
J Oncol
. 2023 May;
2022:7625138.
PMID: 37223641
Accurate risk stratification for patients with serous ovarian cancer (SOC) is pivotal for treatment decisions. In this study, we identified a lncRNA-based signature for predicting platinum resistance and prognosis stratification...
7.
Xie B, Lin X, Wu K, Chen J, Qiu S, Luo J, et al.
Environ Res
. 2022 Nov;
216(Pt 4):114779.
PMID: 36370816
Evidence indicates that individual or groups of polybrominated diphenyl ethers (PBDEs) are associated with risk of breast cancer (BC). Epidemiological studies of PBDEs and BC progression are scarce. This study...
8.
Yang Z, Ye X, Zhang Y, Huang Y, Chen J, Zeng Y, et al.
Cytotechnology
. 2022 Apr;
74(2):231-243.
PMID: 35464163
Supplementary Information: The online version contains supplementary material available at 10.1007/s10616-022-00520-8.
9.
Chen J, Zhuang Y, Wang P, Ning J, Liu W, Huang Y, et al.
Cell Death Dis
. 2022 Mar;
13(3):216.
PMID: 35256595
DNA N6-methyladenosine (6mA) is a novel epigenetic signaling modification in humans and has been implicated in the progression and tumorigenesis of several cancers. However, the function and mechanism of 6mA...
10.
Chen J, Zhou Z, Lin X, Liao J, Zhang Y, Xie B, et al.
Front Cell Dev Biol
. 2022 Mar;
10:792933.
PMID: 35252173
Cadmium (Cd) exposure has been implicated in the etiology of esophageal squamous cell carcinoma (ESCC), albeit with inconsistent results from epidemiologic studies and without causal evidence. In this study, we...